Physician profile
David Whiteman
NPI 1467513812
$3,270.10
in general payments reported to CMS, 2019-2025
14 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $821 · 2020: $133 · 2021: $137 · 2022: $660 · 2023: $513 · 2024: $718 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,194 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,193.91 |
| Long Term Medical Supply Or Device Loan | $325.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $883.35 | 2019-2025 | |
| Davol INC. | $668.14 | 2022-2024 | Phasix Mesh |
| Galderma Laboratories, L.P. | $355.42 | 2020-2025 | Dysport |
| Integra Lifesciences Corporation | $346.28 | 2024 | Durasorb Monofilament Mesh, Integra, Omnigraft |
| Tepha INC | $296.14 | 2019 | |
| Tela Bio, INC. | $206.25 | 2022-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Mentor Worldwide LLC | $164.37 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $160.89 | 2019-2022 | |
| Abbvie INC. | $85.57 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Ethicon US, LLC | $31.34 | 2021-2025 | Vistaseal |
| Sientra, INC. | $21.03 | 2022 | |
| Fidia Pharma USA INC. | $20.76 | 2025 | Triluron, Hymovis |
| Acera Surgical, INC. | $16.58 | 2020 | |
| Smith+Nephew, INC. | $13.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Whiteman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.